David Domzalski
2022
In 2022, David Domzalski earned a total compensation of $1.3M as President and Chief Executive Officer at VYNE Therapeutics, a 73% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $325,156 |
|---|---|
| Option Awards | $128,044 |
| Salary | $637,560 |
| Stock Awards | $190,504 |
| Other | $12,200 |
| Total | $1,293,464 |
Domzalski received $637.6K in salary, accounting for 49% of the total pay in 2022.
Domzalski also received $325.2K in non-equity incentive plan, $128K in option awards, $190.5K in stock awards and $12.2K in other compensation.
Rankings
In 2022, David Domzalski's compensation ranked 2,529th out of 5,676 executives tracked by ExecPay. In other words, Domzalski earned more than 55.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,529 out of 5,676 | 55th |
Division Manufacturing | 1,392 out of 3,084 | 55th |
Major group Chemicals And Allied Products | 631 out of 1,399 | 55th |
Industry group Drugs | 585 out of 1,300 | 55th |
Industry Pharmaceutical Preparations | 417 out of 942 | 56th |
Source: SEC filing on November 13, 2023.
Domzalski's colleagues
We found two more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2022.